Warren, Richard D.
7690  results:
Search for persons X
?
 
?
2

Bimekizumab 3-year Safety and Tolerability in Moderate to S..:

Lebwohl, Mark ; Strober, Bruce ; Langley, Richard G....
SKIN The Journal of Cutaneous Medicine.  8 (2024)  1 - p. s305 , 2024
 
?
4

A Matching-Adjusted Indirect Comparison of the Efficacy of ..:

Warren, Richard ; McInnes, Iain ; Nash, Peter...
SKIN The Journal of Cutaneous Medicine.  8 (2024)  1 - p. s312 , 2024
 
?
5

Bimekizumab Versus Secukinumab Continuous Maintenance of PA..:

Merola, Joseph ; Conrad, Curdin ; Foley, Peter...
SKIN The Journal of Cutaneous Medicine.  8 (2024)  2 - p. s403 , 2024
 
?
6

Effect of Subcutaneous Spesolimab on the Prevention of Gene..:

Warren, Richard ; Burden, David ; Choon, Siew Eng...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  6 - p. s245 , 2023
 
?
7

P66 Uptake of biosimilars for psoriasis: a drug utilization..:

Phan, Duc Binh ; Bewley, Anthony ; Smith, Catherine...
British Journal of Dermatology.  188 (2023)  Supplement_4 - p. , 2023
 
?
8

DP04 Role of multidisciplinary team meetings in management ..:

Shakeel, Musfira ; Foulkes, Amy ; Warren, Richard
British Journal of Dermatology.  188 (2023)  Supplement_4 - p. , 2023
 
?
13

004 Does methotrexate affect treatment persistence or effec..:

Yiu, Zenas ; Smith, Catherine ; Laws, Philip...
British Journal of Dermatology.  188 (2023)  Supplement_4 - p. , 2023
 
?
14

RF02 Using functional genomic techniques to help us underst..:

Elyoussfi, Sarah ; Rane, Shraddha ; Eyre, Stephen.
British Journal of Dermatology.  188 (2023)  Supplement_4 - p. , 2023
 
?
15

3 years of tralokinumab treatment provides long term diseas..:

Warren, Richard ; Reich, Kristian ; Simpson, Eric...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s142 , 2023
 
1-15